Jeffrey Stein
CIK 1478831 · President & CEO · last filed 2026-03-02
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$1.67M
Companies
4
Total Filings
63
Lifetime Open-Market Net
$3.92M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| IDYA | Director | 57,644 | $28.98 | $1.67M | $1.65M | 8 | 2026-03-02 |
| Cidara Therapeutics, Inc. (CDTX) Delisted | President & CEO | 10,072 | $221.38 | $2.23M | $2.31M | 36 | 2026-01-07 |
| Paratek Pharmaceuticals, Inc. (PRTK) Delisted | Director | 0 | $2.23 | $0 | -$37.4K | 12 | 2023-09-21 |
| Trius Therapeutics Inc (TSRX) Delisted | President and CEO | 210,457 | — | — | $0 | 6 | 2013-03-11 |
Recent Filings · Page 6 of 7
63 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2016-05-23 | Cidara Therapeutics, Inc. (CDTX) Delisted | Buy (P) | +4,310 | $49.6K | EDGAR |
| 2016-03-18 | Cidara Therapeutics, Inc. (CDTX) Delisted | Grant (A) | — | $0 | EDGAR |
| 2016-02-08 | Paratek Pharmaceuticals, Inc. (PRTK) Delisted | Grant (A) | — | $0 | EDGAR |
| 2015-11-27 | Cidara Therapeutics, Inc. (CDTX) Delisted | Buy (P) | +6,700 | $101.1K | EDGAR |
| 2015-04-21 | Cidara Therapeutics, Inc. (CDTX) Delisted | Buy (P) | +420 | $6.7K | EDGAR |
| 2015-02-06 | Paratek Pharmaceuticals, Inc. (PRTK) Delisted | Grant (A) | — | $0 | EDGAR |
| 2013-09-13 | — | Disp (D) | −210,457 | $0 | |
| 2013-03-11 | Trius Therapeutics Inc (TSRX) Delisted | Grant (A) | — | $0 | EDGAR |
| 2012-03-28 | Trius Therapeutics Inc (TSRX) Delisted | Exer (M) | +38,462 | $20.0K | EDGAR |
| 2012-03-12 | Trius Therapeutics Inc (TSRX) Delisted | Grant (A) | — | $0 | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.